SPARROW PHARMACEUTICALS
Dead / Abandoned — Abandoned — after ex parte appeal (as of 10 Jan 2023)
What this means for you
This application is over — abandoned 10 Jan 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88817597
- Mark type
- Stylized text
- Filed
- 02 Mar 2020
- Abandoned
- 10 Jan 2023
- Attorney of record
- SEAN D O'BRIEN
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of allergic states, collagen diseases, dermatologic diseases, edematous states, endocrine disorders, gastrointestinal diseases, hematological disorders, infectious diseases, neoplastic diseases, nervous system disorders, ophthalmic diseases, respiratory disorders, and rheumatic disorders
Owner
- Sparrow Pharmaceuticals, Inc., Portland, OR, US
Prosecution history
- 10 Jan 2023 — ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
- 10 Jan 2023 — ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
- 10 Jan 2023 — ABANDONMENT - AFTER EX PARTE APPEAL
- 10 Jan 2023 — EXPARTE APPEAL TERMINATED
- 23 Nov 2022 — EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
- 26 Aug 2022 — NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
- 26 Aug 2022 — ACTION DENYING REQ FOR RECON E-MAILED
- 26 Aug 2022 — ACTION CONTINUING FINAL - COMPLETED
- 18 Aug 2022 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 24 May 2022 — EX PARTE APPEAL-INSTITUTED
- 24 May 2022 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 20 May 2022 — EXPARTE APPEAL RECEIVED AT TTAB
- 22 Nov 2021 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 22 Nov 2021 — FINAL REFUSAL E-MAILED
- 22 Nov 2021 — FINAL REFUSAL WRITTEN